The ROE as of November 2024 (TTM) for Selecta Biosciences, Inc. (SELB) is 67.13%

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 67.13%. This represents a change of -501.67% compared to the average of -16.71% of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical ROE (quarterly & annually)

How has SELB ROE performed in the past?

The mean historical ROE of Selecta Biosciences, Inc. over the last ten years is 77.38%. The current 67.13% ROE has changed -13.25% with respect to the historical average. Over the past ten years (40 quarters), SELB's ROE was at its highest in in the December 2018 quarter at 270.41%. The ROE was at its lowest in in the June 2019 quarter at -29275.00%.

Selecta Biosciences, Inc. (SELB) ROE by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Selecta Biosciences, Inc. (SELB) Average ROE

How has SELB ROE performed in the past?

The current ROE of Selecta Biosciences, Inc. (SELB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Selecta Biosciences, Inc. (SELB) ROE vs. Peers

How is SELB’s ROE compared to its peers?

Selecta Biosciences, Inc.’s ROE is less than Paratek Pharmaceuticals, Inc. (22.36%), greater than Corvus Pharmaceuticals, Inc. (-53.99%), greater than Immutep Limited (-42.11%), greater than Icosavax, Inc. (-41.24%), less than Checkpoint Therapeutics, Inc. (292.43%), less than Mustang Bio, Inc. (1.40%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Fortress Biotech, Inc. (-226.63%), greater than Kodiak Sciences Inc. (-77.23%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Eyenovia, Inc. (-615.55%), greater than Cognition Therapeutics, Inc. (-118.11%), greater than TransCode Therapeutics, Inc. (-597.47%), less than Gamida Cell Ltd. (187.96%), less than Rigel Pharmaceuticals, Inc. (46.64%), greater than Geron Corporation (-73.79%), greater than ImmunoGen, Inc. (-21.97%), greater than Cidara Therapeutics, Inc. (-401.89%), greater than Fortress Biotech, Inc. (-226.63%),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.